Stock & Company Details
CytoMed Therapeutics Ltd $GDTC
Price:
N/A
N/A
12M
$9.2M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.26
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GDTC technical indicators
Latest CytoMed Therapeutics Ltd (GDTC) indicator readings as of 2026-11-19.
GDTC's 14-day RSI is 37.5, in neutral territory. ADX reads 34.3, indicating a trending market. MACD (12, 26, 9) is -0.03, below the zero line.
Overview
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is majority revenue generator.
Finance Bot
Ask your questions
Start by typing a question below.